Health Care
(E86)
IRS Verified
DX Registered
990 on File
PTEN HAMARTOMA TUMOR SYNDROME FOUNDATION
Financial strength (30%)
73/100
Reliability (20%)
50/100
Effectiveness (25%)
73/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The PTEN Hamartoma Tumor Syndrome Foundation was founded to find treatments or therapies for PTEN Syndromes by funding research, providing PHTS education, supporting patients, and by raising awareness. PHTS includes Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), PTEN-related Proteus syndrome (PS), and Proteus-like syndrome.
Financial Overview — FY 2023
$74K
Total Revenue
$67K
Total Expenses
$115K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
100.8%
Fundraising Efficiency
N/A
Operating Reserve
20.70x
Liability-to-Asset
23.3%
Revenue Diversification
95.3%
Compared with Peers
FY 2023
Compared with 4,805 similar organizations
(United States, Health Care, under $100K in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
100.8% | 80.5% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
20.7 mo | 29.2 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
23.3% | 0.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
95.3% | 99.9% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
20.9% | -2.7% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-2.6% | -1.4% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
10.0% | 13.1% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $74K | $67K | $115K | 100.8% | — |
| 2022 | $61K | $69K | $108K | 99.3% | — |
| 2021 | $180K | $62K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.